Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrowing Losses Overshadowed by Flat Drug Pipeline ICCM Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development DEFSEC Technologies Q2 2024 Earnings EPS Miss Weighs on Results as Stock Gains Despite Weakness RxSight Q1 2026 Earnings EPS Misses Estimates by 32 as Operational Costs Weigh TKNO Q1 2026 Earnings Narrower Loss Beats Expectations Despite Revenue Uncertainty SLSR Q1 2026 Earnings Narrowing Losses Despite Market Headwinds